000 01999 a2200541 4500
005 20250514004718.0
264 0 _c20010920
008 200109s 0 0 eng d
022 _a0304-3835
024 7 _a10.1016/s0304-3835(01)00574-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aClarke, K O
245 0 0 _aTributyrin, an oral butyrate analogue, induces apoptosis through the activation of caspase-3.
_h[electronic resource]
260 _bCancer letters
_cSep 2001
300 _a57-65 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdenocarcinoma
_xenzymology
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aButyrates
_xpharmacology
650 0 4 _aCDC2-CDC28 Kinases
650 0 4 _aCaspase 3
650 0 4 _aCaspases
_xmetabolism
650 0 4 _aCell Cycle Proteins
650 0 4 _aColonic Neoplasms
_xenzymology
650 0 4 _aCyclin-Dependent Kinase 2
650 0 4 _aCyclin-Dependent Kinases
_xmetabolism
650 0 4 _aDNA-Binding Proteins
_xmetabolism
650 0 4 _aE2F Transcription Factors
650 0 4 _aE2F4 Transcription Factor
650 0 4 _aEnzyme Activation
_xdrug effects
650 0 4 _aG1 Phase
_xdrug effects
650 0 4 _aNeoplasm Proteins
_xmetabolism
650 0 4 _aNuclear Proteins
_xmetabolism
650 0 4 _aPhenotype
650 0 4 _aPhenylbutyrates
_xpharmacology
650 0 4 _aPhosphorylation
_xdrug effects
650 0 4 _aProtein Processing, Post-Translational
_xdrug effects
650 0 4 _aProtein Serine-Threonine Kinases
_xmetabolism
650 0 4 _aRetinoblastoma Protein
_xmetabolism
650 0 4 _aTranscription Factors
_xmetabolism
650 0 4 _aTriglycerides
_xpharmacology
650 0 4 _aTumor Cells, Cultured
_xdrug effects
700 1 _aFeinman, R
700 1 _aHarrison, L E
773 0 _tCancer letters
_gvol. 171
_gno. 1
_gp. 57-65
856 4 0 _uhttps://doi.org/10.1016/s0304-3835(01)00574-2
_zAvailable from publisher's website
999 _c11412742
_d11412742